Potential Functional Variants in DNA Repair Genes Are Associated with Efficacy and Toxicity of Radiotherapy in Patients with Non-Small-Cell Lung Cancer
Table 3
Association between candidate SNPs and radiation-induced toxic reactions.
Gene
SNPs
Genotype
Low toxic reactions
High toxic reactions
OR (95% CI)
XRCC1
rs25487
CC
188
74
Reference
Reference
CT
114
69
0.650 (0.435–0.972)
0.035
TT
23
18
0.503 (0.257–0.986)
0.043
CT + TT
137
87
0.620 (0.424–0.907)
0.013
rs25489
CC
257
122
Reference
Reference
CT
65
38
0.812 (0.515–1.279)
0.369
TT
3
1
0.424 (0.147–13.83)
0.759
CT + TT
68
39
0.828 (0.528–1.297)
0.409
rs1799782
GG
175
91
Reference
Reference
AG
117
58
1.049 (0.700–1.571)
0.817
AA
33
12
1.430 (0.705–2.902)
0.320
AG + AA
150
70
1.114 (0.762–1.630)
0.577
rs3213245
AA
248
117
Reference
Reference
AG
74
43
0.812 (0.525–1.255)
0.348
GG
3
1
1.415 (0.146–13.75)
0.764
AG + GG
77
44
0.826 (0.537–1.270)
0.383
XRCC2
rs3218544
GG
117
49
Reference
Reference
AG
162
83
0.817 (0.534–1.251)
0.353
AA
46
28
0.688 (0.387–1.224)
0.202
AG + AA
208
111
0.785 (0.523–1.177)
0.241
rs3218385
AA
235
109
Reference
Reference
AC
78
47
0.770 (0.502–1.180)
0.229
CC
12
5
1.113 (0.383–3.238)
0.844
AC + CC
90
52
0.803 (0.533–1.210)
0.293
rs3218556
GG
238
96
Reference
Reference
AG
78
52
0.605 (0.396–0.924)
0.019
AA
9
13
0.279 (0.116–0.675)
0.003
AG + AA
87
65
0.540 (0.362–0.805)
0.002
MSH2
rs2303424
GG
123
52
Reference
Reference
AG
156
82
0.804 (0.528–1.224)
0.309
AA
46
27
0.720 (0.405–1.280)
0.263
AG + AA
202
109
0.783 (0.526–1.168)
0.230
rs2303425
TT
204
106
Reference
Reference
CT
104
45
1.201 (0.788–1.830)
0.394
CC
17
10
0.883 (0.391–1.997)
0.765
CT + CC
121
55
1.143 (0.769–1.698)
0.508
XPD
rs238419
CC
102
43
Reference
Reference
CT
149
77
0.816 (0.520–1.280)
0.375
TT
74
41
0.761 (0.451–1.283)
0.304
CT + TT
223
118
0.797 (0.523–1.213)
0.289
rs13181
TT
235
130
Reference
Reference
GT
82
27
1.680 (1.035–2.728)
0.035
GG
8
4
1.106 (0.327–3.745)
0.871
GT + GG
90
31
1.624 (1.025–2.547)
0.038
The values in bold indicate a statistically significant association. All data are adjusted for age, gender, smoking history, cancer histology, family history, and treatment with chemotherapy.